427 Neurology AG Lasker, DS Zee, TC Hain, SE

at UNIVERSITY PIERRE ET MARIE on November 14, 2008 www.neurology.org ... cated at 0 and at right and left 10,20, and 30 degrees. Head ... of Medicine, Baltimore, MD. ..... se is the explanation. Rather ... Administration of the latter, which.
618KB taille 13 téléchargements 195 vues
Saccades in Huntington's disease: Slowing and dysmetria A. G. Lasker, D. S. Zee, T. C. Hain, S. E. Folstein and H. S. Singer Neurology 1988;38;427

This information is current as of November 14, 2008

The online version of this article, along with updated information and services, is located on the World Wide Web at: http://www.neurology.org

Neurology® is the official journal of the American Academy of Neurology. Published continuously since 1951, it is now a weekly with 48 issues per year. Copyright © 1988 by AAN Enterprises, Inc. All rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.

Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 14, 2008

Saccades in Huntington’s disease: Slowing and dysmetria A.G. Lasker, MS; D.S. Zee, MD; T.C. Hain, MD; S.E. Folstein, MD; and H.S.Singer, MD

Article abstract-Eye movements were recorded from 20 mildly affected patients with Huntington’s disease (HD) who were divided into two groups, 10 patients with onset of symptoms before age 30 and 10 with onset of symptoms after age 30. In the younger onset group (HD < 30). peak saccade velocities were low ( 30) had peak saccade velocities lower than 300 deg/sec. Latencies for volitional saccades were greater than normal in the HD > 30 group, but were normal for the HD < 30 group. The ability to maintain steady fixation in the face of a distracting visual stimulus was decreased, to the same degree, in both groups of HD patients. In addition, 70%of the HD < 30 group had an affected father, while 70%of the HD > 30 group had an affected mother. These findings suggest that the pathophysiology of the slow saccades, initiation deficit, and excessive distractibility in HD are different. NEUROLOGY 1988;38427-431

In a recent study of eye movements in mildly affected patients with Huntington’s disease (HD), we found abnormalities of both the initiation of saccades as well as the ability to hold steady fixation.’ Most patients showed a n increase in saccade latencies that was greater for saccades made on command (voluntary saccades) than for saccades made to the sudden appearance of a visual stimulus (reflexive saccades). All patients showed excessive distractibility;they had difficulty in suppressing a saccade to a suddenly appearing visual target even though they were i n s t r u c t e d e i t h e r t o m a i n t a i n straight-ahead fixation or to make a saccade in the direction opposite to the visual target. We attributed these abnormalities to involvement of the frontal eye fields or basal ganglia in HD. In the present study, we report further abnormalities of eye movements-saccade slowing andsaccade dysmetria-in the same group of patients, and compare these findings with their deficits in saccade initiation and in holding steady fixation. Slow saccades have been noted in patients with HD with a reported prevalence of 18% to 100%.2-10 While one study did seem to show a correlation between the age of the patient and the saccade ~ e l o c i t y few , ~ attempts have been made t o correlate saccade slowing with other saccade abnormalities i n HD or with patient age or severity or duration of i l l n e ~ s . ~In J ~contrast J~ to the saccade initiation and the fixation deficits, which have been attributed to involvement of the basal ganglia or cerebral hemispheres, saccade slowing has usually been attributed t o direct pathologic involvement of the intrinsic brainstem structures that generate the immediate premotor commands for saccadic eye move-

m e n t ~ . Accordingly, ~-~ t o better understand the eye movement abnormalities in HD, we compared disorders of saccade velocity and accuracy with other types of saccade deficits in HD. Methods. The subjects sat in front of an arc (radius, 123 cm) that contained an array of light-emitting diodes (LEDs), located at 0 and at right and left 10,20, and 30 degrees. Head movements were restricted by the use of a chin rest. Patients were in complete darkness except for the LEDs. Movements of the right eye were recorded with directcurrent electro-oculography(EOG). The analog signals were low-passfiltered (40 Hz), digitizedat a rate of 100Hz on a PDP 11/73 microcomputer,and stored on magnetic tape for off-line analysis. Testing paradigms. Saccades were elicited in three paradigms. For each paradigm the same cue signaled the time to initiate a saccade.The cue consisted of turning off the center fixation LED coupled with a nonlocalizable 100-msecauditory beep. In each paradigm, the trial began with fixation of an LED located at 0 degrees. At a random time (1,400 to 2,400 msec), direction (right or left), and amplitude (10, 20, or 30 deg), one of the peripherally located LEDs was illuminated. For each testing paradigm, 60 trials were elicited. Paradigm NS (nooel stimulus). The peripheral LED was illuminated, and simultaneously, the central fixation LED was extinguished and the beep sounded. This paradigm tested the ability of the patient to initiate saccades to a suddenly appearing visual stimulus. Paradigm CS (continuous stimulus). The peripheral LED was illuminated, but the patient was instructed not to make a saccade to it until the cue occurred (1,000 to 1,800 msec). This paradigm tested the ability of a patient both to suppress a reflexive saccade to a suddenly appearing visual target and to make a saccade on command to a continuously visible target.

From the Departmentaof Ophthalmology (MI. Lasker),Neurology (DIE.Zee.Hain, and Singer),and Psychiatry (Dr. Folstein), The Johns Hopkins University, School of Medicine, Baltimore, MD. Supported by NIH grant 2 PO1 NS16375 and EY01765. Received June 11.1987. Accepted for publication in final form July 23,1987. Addreaa correspondence and reprint requests to MI. Lasker, Wilmer Eye Institute. Woods 355, The Johns Hopkins Hospital, Baltimore, MD 21205.

March 1988 NEUROLOGY 38 427 Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 14, 2008

VELOCITY 1

r l

LATENCY

1

1

T

C

H, NS

Hz

C

H,

cs

H2

C

HI RS

H2

Figure 1. Peak velocity for 20-degree saccades of the three groups of subjects for all three paradigm. n = 18 for the comparison group (C); n = 6 for each of the HD groups, H D < 30 ( H I )and HD > 30 ( H J . N S = novel stimulus; CS = continuous stimulus; and RS = remembered stimulus. Bars reflect the standard deviation for each group. H I shows slow saccades for all paradigms compared with either the comparison group or H2.

Paradigm RS (remembered stimulus). This paradigm was identical to paradigm CS above, except that the peripheral LED was extinguished after it had been illuminated for 1,500 msec. Then, 1,000 to 2,000 msec later, the cue occurred. This paradigm tested the ability of a patient to both suppress a saccade to a suddenly appearing visual target and to make a saccade on command to the remembered location of a visual target. Data analysis. We determined maximum saccade velocities, saccade amplitudes, and saccade latencies, using an interactive computer program that displayed each trial for review by the experimenter. The accuracy of the eye movement was expressed as a percentage, using the ratio of the amplitude of the initial eye movement to the amplitude of the target displacement and multiplying by 100. Each trial was individually calibrated to eliminate inaccuracy due to fluctuation in the amplitude of the corneoretinal potential. Peak velocity of saccades were determined by computer using a digital differentiator with a 0- to 40-Hz bandwidth. We determined latencies from the time of cue onset to the time of saccade initiation. All statistical comparisons were based on the Student’s t test.

Clinical data. We studied 20 patients with HD and a comparison group of 18 subjects. All the HD patients were minimally to mildly affected with respect to both cognition and motor performance.’ The HD population was divided into two groups based on the patient’s age at the onset of symptoms. These symptoms were determined by interviews with a family member living with 428 NEUROLOGY 38 March 1988

NS

CS

RS

Figure 2. Latency of the three groups of subjects for all three paradigms. n = 18 for the comparison group (C); n = 6 for each of the H D groups, H D < 30 (H,) and H D > 30 (HA. N S = novel stimulus; CS = continuous stimulus; and RS = remembered stimulus. Bars reflect the standard deviation for each group. H,has a significantly longer latency than either the comparison group or H I for the CS and RS paradigms.

the patient at the time of onset. Using this family informant, we documented the year of onset of any movement disorder. To increase the accuracy of estimating onset, we used a semistructured interview that helped the informant put symptoms in the context of documented life events.12J3 The younger onset group (HD < 30) consisted of 10 patients (mean age at onset 22.8 yrs f 4.8 yrs [SD]; range, 16 to 29 yrs). The older onset group (HD > 30) also consisted of 10 patients (mean age a t onset 50.6 yrs f 8.9 yrs [SD]; range, 36 to 63 yrs). The durations of illness for the two groups were similar; for the younger group, 4.5 yrs k 4.3 yrs (SD),range 1 to 15 years; and for the older group, 3.1 yrs f 2.9 yrs (SD), range 1to 10 yrs. A t the time of recording, the age range of the younger onset group was 17 to 36 years, while the range of the older onset group was 36 to 65 years. Seventy percent of the younger onset group had an affected father, while 70% of the older onset group had an affected mother. The degree of severity of HD in both patient groups was also comparable. There were no statistically significant differences in the Quantitative Neurological Examination (QNE), Activities of Daily Living (ADL), or the Mini-Mental Status Examination.14J5Three of the patients with HD were taking phenothiazine medication,

Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 14, 2008

Table. Velocity, latency, and accuracy of all HD patients (n = 20) and the comparison group in the novel stimulus (NS)and continuous stimulus (CS) paradigms

ma ACCURACY IK

HD < 30*

IOC

T T T

Velocity NS

1

T

cs

t-

z

W

oc

HD > 30*

Comparisont

SD

237 89

392 51

420 55

350 54

391 66

P I

221

SD

88

Latency

W

a

NS

cs

a(

X

270

SD

59

285 47

243 39

K

359 68

493 94

303 55

SD Accuracy NS

T(

cs

x SD

85.9 12.0

95.2 3.0

93.9 4.6

X

87.0

SD

12.0

97.0 4.0

95.9 3.9

(n = 10).

61

t (n = 18). NS

cs

RS

Figure 3. Accuracy for all three groups of subjects for whom data were available for all three paradigms. n = 18 for the comparison group (C); n = 6 for each of the HD groups, HD < 30 (H,) and HD > 30 (HA. NS = novel stimulus; C S = continuous stimulus; and RS = remembered stimulus. Bars reflect the standard deviation for each group. The accuracy of the saccades made by the HD groups are essentially the same for the N S and CS paradigms, but differ significantly for the RS paradigm.

four were taking tricyclic antidepressants, and one was taking baclofen. The number of HD patients taking medications was divided equally between the two age groups. The comparison group consisted of 10 normal individuals, four subjects with developmental dyslexia, and four patients with Gilles de la Tourette’s syndrome,two of whom were taking neuroleptic medications. The mean age of the comparison group was 36.2 years 18.6 years (SD), with a range of 14 to 69 years.

*

Results. Figures 1,2, and 3 compare the peak velocities, latencies, and accuracies of 20-degree saccades for the three groups for each of the three paradigms. The HD groups consisted of six patients each, for whom we had data for all three paradigms. The table summarizes the means and standard deviations for all 20 HD patients in whom data for just the NS and CS paradigms were available. Peak uelocity. The mean value for peak saccade velocity progressively decreased from paradigm NS to RS for each group (figure 1). However, for all paradigms, HD patients who acquired their symptoms prior to the age of 30 (HD < 30 or H,) had significantly lower (p < 0.01) peak velocitiesthan those of the older HD patients

or the comparison group. The patients who acquired their symptoms after the age of 30 (HD > 30 or H,) had peak velocities that did not differ significantlyfrom the comparison group. Figure 4 shows the mean peak velocity for 20-degree saccades for all HD patients in the NS paradigm. Defining a 20-degree saccade as slow if its peak velocity is less than 255 deg/sec (3 SDs below the mean of the comparison group), 60% of the patients in the HD < 30 group but none in the HD > 30 group were abnormal. Latency. There was no significant difference in mean saccade latencies of any group for the NS paradigm (figure 2). For paradigms CS and RS, however, the values from the HD > 30 group were significantly greater (p < 0.05) than those from either the HD < 30 group or the comparison group. In contrast, there was no difference in mean saccade latency among the comparison subjects when they were divided into the same two age groups. Accuracy. For the NS and CS paradigms, the accuracy of 20-degree saccades made by patients in the two HD groups (figure 3) did not differ significantly from each other or from the comparison group. In the RS paradigm, however, there was a small but significant difference between each of the HD groups and the comparison group (p < 0.05) and a larger difference between the HD groups themselves (p < 0.002). The HD < 30 group made hypometric saccades in the RS paradigm, and the HD > 30 group made hypermetric saccades in the same paradigm. As reported previously,’ HD patients showed significantly more distractibility (inappropriate saccades to the sudden appearance of a target in the periphery when instructed to maintain straight-ahead fixation) than March lBSS NEUROLOGY 38 429

Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 14, 2008

500

400

>

t V

0 0 J W

urn

> \ y

300

u o W

a

20 0

IOC

1 I

1-

HD

> 30

controls (p < 0.005). There was no significant difference between the percent errors for the HD < 30 (19.4%)and HD > 30 (27.7%) group. A comparison of both the HD and the Tourette’s syndrome patients failed to find any relationship between use of medications and the velocity, latency, or accuracy of their saccades.

Discussion. Relationship of age at onset and saccade abnormalities in HD. The age at onset of HD appeared to influence the type of saccade abnormalities shown by our patients. Increased saccade latencies were present primarily in the HD > 30 group, especially for the CS and RS paradigms, while slow saccades were present only in the HD < 30 group. In our mildly affected patients, age at symptom onset, not duration of the illness, determined whether or not latencies or velocities were abnormal. This is not to say that older people do not develop slow saccades eventually. They do; but our results indicate that patients who are only mildly affectedwith HD and who have slow saccadesare likely to be young. On the other hand, increased distractibility was present in all HD patients and did not appear to be age related. These findingssuggest that the pathophysiology of the slow saccades, of the initiation deficits, and of the excessive distractibility shown by patients with HD are different. Why might age at onset influence the nature of the saccade abnormalities in HD? It is unlikely that age per se is the explanation. Rather, some common genetic factor probably accounts for both the differences in the age at onset and the type of eye movement deficit. For

16

HD 30 group all had average peak velocities above 300 degl sec, whereas six patients in the HD < 30 group had average peak velocities less than 255 deglsec. Numbers below each bar signify patient identification.

example, Myer and his group16found a correlation between the age at onset of symptoms and the gender of the affected parent. Persons who showed symptoms of HD at an early age were more likely to have inherited the gene from the father, those later in life from the mother. This was true in our patients; 70% of the younger group inherited HD from their father and 70% of the older group inherited HD from their mother. Clinical differences between the younger and the older onset groups may also be related to differencesin the patterns of biochemical abnormalities and distribution of loss of nerve fibers described for each g r 0 ~ p . l ~ Mechanism of slow saccades in HD. We have argued previously that the defects in saccade initiation and the excessive distractibility in HD reflect abnormalities in the frontal lobes or basal ganglia, or both. The origin of the saccade slowing is less clear. Slow saccades have usually been attributed to abnormalities in the brainstem reticular formation and in particular the burst cells that generate the immediate premotor commands for saccadic eye movements. There is, however, recent evidence that slow saccades may also be caused by abnormalities in higher level circuits that trigger the brainstem networks that generate saccades.18In addition, some patients with HD who had documented slow (vertical) saccades in life showed no pathologic abnormalities, other than a mild gliosis, in the regions of the brainstem where the burst neurons for vertical saccades are 10cated.l~Finally, Hikosaka and Wurtz20,2L have shown that slow saccades occur with pharmacologic lesions-either with lidocaine or muscimol-of the superior colliculus. Administration of the latter, which

430 NEUROLOGY 38 March 1988

Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 14, 2008

appears to mimic excessive inhibition of the superior colliculus by the substantia nigra pars reticulata, leads to slowing of all types of saccades and to dysmetria of volitional saccades, especially those made to the remembered location of a target. Our younger patients with HD showed just this combination of deficits. How might disturbances of suprandclear control of burst neurons lead to slow saccades? Abnormal inputs to pontine pause neurons might lead to slow saccades.22 Normally, pause cells act to inhibit burst neurons. When a saccade is called for, pause neurons must cease discharging to disinhibit burst neurons and permit them to generate a saccade. Accordingly, slow saccades could occur if only a fraction of the pause cells were inhibited, thereby allowing only a fraction of the burst cells to discharge. Alternatively, if a portion of the direct, cerebral, or collicular projections to burst neurons are affected in HD, slow saccades might occur because only a fraction of the burst neurons might be recruited during the saccade. Of course there also may be nonspecific higher-level tonic influences upon brainstem neurons which, if lost, could account for a decrease in the sensitivity of burst neurons to supranuclear inputs and consequently lead to slow saccades. In any case, the initial cause of the slow saccades in HD may not be due to direct involvement of brainstem burst neurons, although the exceedingly slow saccades that ultimately develop in some patients may reflect a combination of disturbed supranuclear inputs and direct involvement of the burst neurons in the paramedian reticular formation of the brainstem. Saccade dysmetria in HD. Our patients showed nearly normal accuracy of saccades. Only saccades to remembered targets were inaccurate and then only by a small amount. Experimental lesions in the basal ganglia and superior colliculus do lead to saccadic dysmetria which is greatest for saccades to remembered targets.20.21 The dysmetria shown by our patients may be the clinical correlate of this finding.

Acknowledgments We wish to acknowledge the assistance of LeAaron Cooper, Cheryl Enger, Corena Bridges, Anne McDonnell, and the referral of subjects by Joan Finucci.

References 1. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington’s disease: initiation defects and distractibility. Neurology 1987;37364-370. 2.Starr A. A disorder of rapid eye movements in Huntington’s chorea. Brain 1967;90545-564.

3. Avanzini G, Girotti F, Caraceni T, SpreaficoR. Oculomotor disorders in Huntington’s chorea. J Neurol Neurosurg Psychiatry 1979;42:581-589. 4. Oepen G. Clarenbach P, Thoden U. Disturbances of eye movements in Huntington’s chorea. Arch Psychiat Neurol Sci 1981;229:205-213. 5. Kirkham TH, Guitton D. A quantitative study of abnormal eye movements in Huntington’s chorea using the scleral search coil technique. Neuro-ophthalmology 1984,427-38. 6. Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA. Abnormal ocular motor control in Huntington’s disease. Neurology 1983;33:1268-1275. 7. Rubin AJ, King WM, Snyder L, Shoulson I. Oculomotor distractibility in early Huntington’s disease: a supranuclear disturbance distinct from saccadicslowing. Abstract. Neurology 1985;35(suppl 1):176. 8. Zangemeister WH, Mueller-Jensen A. The co-ordination of gaze movements in Huntington’s disease. Neuro-ophthalmology 1985;5:193-206. 9. Bollen E, Reulen JPH, Den Heyer JC, Van der Kamp W, Roos RAC, Buruma OJS. Horizontal and vertical eye movement abnormalities in Huntington’s chorea. J Neurol Sci 1986;74:11-22. 10. Beenen N, Biittner U, h g e HW. The diagnostic value of eye movement recordings in patients with Huntington’s disease and their offspring. Electroencephalogr Clin Neurophysiol 1986;63:119-127. 11. Caviness VS. Huntington’s disease. Dev Med Child Neurol 1985;27:826-829. 12. Folstein SE, Leigh RJ,Parhad IM, Folstein MF. The diagnosis of Huntington’s disease. Neurology 1986;361279-1283. 13. Folstein SE, Chase GA, Wahl WE, McDonnell AM, Folstein MF. Huntington’s disease in Maryland clinical aspects of racial variation. Am J Hum Genet 1987;41:168-179. 14. Folstein SE, Jensen BR, Leigh RJ, Folstein MF. The measurement of abnormal movement: methods developed for Huntington’s disease. Neurobehav Toxicol Teratol 1983;5:605-609. 15. Anthony JC, LeResche L, Niaz U, Van Kopff HH, Folstein MF. Limits of the ‘mini-mental state’ as a screening test for dementia a n d delirium among- h o s p i t a l p a t i e n t s . Psycho1 Med 1982;12:397-408. 16. Myers RH, Goldman D, Bird ED, Sax DS, Merril CR, Schoenfeld M. Wolf PA. Maternal transmission in Huntineton’s disease. Lancet 1983;29:208-210. 17. Albin RL, Reiner A, Anderson KD, D’Amato CJ, Penney JB, Young AB. Differential loss of substance-p-containing and enkephalin-containing striatofugal projections in adult-onset and juvenile-onset Huntington’s disease. SOCNeurosci Abs 1987;13:1360. 18. Deng SY, Goldberg ME, Segraves MA, Ungerleider LG, Mishkin M. The effect of unilateral ablation of the frontal eye fields on saccadic performance in the monkey. In: Keller EL, Zee DS. eds. Adaptive processes in visual and oculomotorsystems. Oxford, U K Pergamon Press, 1986:201-208. 19. Leigh JR, Parhad IM, Clark AW, Buettner-Ennever JA, Folstein SE. Brainstem findings in Huntington’s disease: possible mechanisms for slow vertical saccades. J Neurol Sci 1985;71:247-256. 20. Hikosaka 0,Wurtz RH. Saccadic eye movements following injection of lidocaine into the superior colliculus. Exp Brain Res 1986;61:531-539. 21. Hikosaka 0,Wurtz RH. Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus. J Neurophysiol 1985;53:266-291. 22. Hain TC, Zee DS, Mordes M. Blink-induced saccadic oscillations. Ann Neurol 1986:19:299-301.

-

March14, 1988 NEUROLOGY 38 431 Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 2008

Saccades in Huntington's disease: Slowing and dysmetria A. G. Lasker, D. S. Zee, T. C. Hain, S. E. Folstein and H. S. Singer Neurology 1988;38;427 This information is current as of November 14, 2008 Updated Information & Services

including high-resolution figures, can be found at: http://www.neurology.org

Permissions & Licensing

Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at: http://www.neurology.org/misc/Permissions.shtml

Reprints

Information about ordering reprints can be found online: http://www.neurology.org/misc/reprints.shtml

Downloaded from www.neurology.org at UNIVERSITY PIERRE ET MARIE on November 14, 2008